Risk of Infectious Complications in Patients Taking Glucocorticosteroids

Reviews of Infectious Diseases

Volumn 11, Issue 6, 1989, Pages 954-963

  Stuck, Andreas E ^a   Minder, Christoph E ^a   Frey, Felix J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; FEMALE; HUMAN; INCIDENCE; INFECTION; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; GLUCOCORTICOIDS; HUMAN; INCIDENCE; INFECTION; MALE; META-ANALYSIS; MIDDLE AGE; RANDOMIZED CONTROLLED TRIALS; SUPPORT, NON-U.S. GOV'T;

EID: 0024762524     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/11.6.954     Document Type: Article

References (103)

1. Cupps TR, Fauci AS. Corticosteroid-mediated immunoreg-ulation in man. Immunol Rev 1982;65:133-55
2. Frey BM, Walker C, Frey FJ, de Weck AL. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 1984;133:2479-87
3. Kass EH, Finland M. Adrenocortical hormones in infection and immunity. Ann Rev Microbiol 1953;7:361-88
4. Kass EH, Finland M. corticosteroids and infections. AdvIntern Med 1958;9:45-80
5. Kass EH. Hormones and host resistance to infection. Bacteriological Reviews 1960;24:177-85
6. Rocci ML Jr, Johnson NF, Jusko WJ. Serum protein binding of prednisolone in four species. J Pharm Sei 1980; 69:977-80
7. Frey FJ, Frey BM, Greither A, Benet LZ. Prednisolone clearance at steady state in dogs. J Pharmacol Exp Ther 1980;215:287-91
8. Frey BM, Sieber M, Mettler D, Gänger H, Frey FJ. Markedinterspecies differences between humans and pigs in cy-closporin and prednisolone disposition. Drug Metab Dispos 1988;16:285-9
9. Arneil GC. One hundred sixty four children with nephrosis. Lancet 1961;2:1103-10
10. Meyers S, Janowitz HD. Crohn’s disease Complications. In: Berk JE, ed. Bockus gastroenterology. Vol. 4. 4th ed. Philadelphia: W. B. Saunders, 1985:2294-305
11. Hoyumpa AM Jr, Schenker S. Hepatic encephalopathy. In: Berk JE, ed. Bockus gastroenterology. Vol. 5. 4th ed. Philadelphia: W. B. Saunders, 1985:3083-120
12. Eickhoff TC. Nosocomial infections. In: Hoeprich PD, ed. Infectious diseases. A modern treatise of infectious processes. 2nd ed. Hagerstown, Md: Harper & Row, 1977: 27-33
13. Buchanan WW. Clinical features of rheumatoid arthritis. In: Scott JT, ed. Copeman’s textbook of the rheumatic diseases. 5th ed. New York: Churchill Livingstone, 1978: 318-64
14. Stamm WE, Türck M. Urinary tract infection, pyelonephritis, and related conditions. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison’s principles of internal medicine. Vol. 2. 11th ed. New York: McGraw-Hill, 1987:1189-95
15. Hirschmann JV, Murray JF. Pneumonia and lung abscess. In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison’s principles of internal medicine. Vol. 2.11th ed. New York: McGraw- Hill, 1987:1075-82
16. Tramont EC. General or nonspecific host defense mechanisms. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practice of infectious diseases. 2nd ed. New York: John Wiley & Sons, 1985:25-31
17. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta-analyses of randomized controlled trials. N Engl J Med 1987;316:450-5
18. Thacker SB. Meta-analysis: a quantitative approach to research integration. JAMA 1988;259:1685-9
19. Bauer RB, Tellez H. Dexamethasone as treatment in cerebrovascular disease. 2. A controlled study in acute cerebral infarction. Stroke 1973;4:547-55
20. Beerel F, Jick H, Tyler JM. A controlled study of the effect of prednisone on air-flow obstruction in severe pulmonary emphysema. N Engl J Med 1963;268:226-30
21. Beerel FR, Vance JW. Prednisone treatment for stable pulmonary emphysema. Am Rev Respir Dis 1971;104:264-6
22. Bennett AE, Ingram GIC. A controlled trial of long-termsteroid treatment in haemophilia. Lancet 1967;1:967-70
23. Binder A, Hazleman BL, Parr G, Roberts S. A controlled study of oral prednisolone in frozen shoulder. Br J Rheumatol 1986;25:288-92
24. Black DAK, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J 1970;3:421-6
25. Blair GP, Light RW. Treatment of chronic obstructive pulmonary disease with corticosteroids. Comparison of daily vs. alternate-day therapy. Chest 1984;86:524-8
26. Blitzer BL, Mutchnick MG, Joshi PH, Phillips MM, Fessel JM, Conn HO. Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. American Journal of Digestive Disorders 1977;22;477-84
27. Blockey NJ, Wright JK, Kellgren JH. Oral cortisone therapy in periarthritis of the shoulder. A controlled trial. Br Med J 1954;1:1455-7
28. Braakman R, Schouten HJA, Blaauw-van Dishoeck M, Minderhoud JM. Megadose steroids in severe head injury. Results of a prospective double-blind clinical trial. J Neu- rosurg 1983;58:326-30
29. Campra JL, Hamlin EM, Kirshbaum RJ, Olivier M, Redeker AG, Reynolds TB. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med 1973;79:625-31
30. Chamberlain MA, Keenan J. The effect of low doses of prednisolone compared with placebo on function and on the hypothalamic pituitary adrenal axis in patients with rheumatod arthritis. Rheumatology and Rehabilitation 1976; 15:17-23
31. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand 1982;148:653-5
32. Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibro- sitis. J Rheumatol 1985;12:980-3
33. Collaborative study of the adult idiopathic nephrotic syndrome. A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979;301:1301-6
34. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971;40:159-85
35. Cooper PR, Moody S, Clark WK, Kirkpatrick J, Maravilla K, Gould AL, Drane W. Dexamethasone and severe head injury. A prospective double-blind study. J Neurosurg 1979;51:307-16
36. Copenhagen Study Group for Liver Diseases. Effect of prednisone on the survival of patients with cirrhosis of the liver. Lancet 1969;1:119-21
37. De Almeida M, Feneux D, Rigaud C, Jouannet P. Steroid therapy for male infertility associated with antisperm antibodies. Results of a small randomized clinical trial. Int J Androl 1985;8:111-7
38. Depew W, Boyer T, Omata M, Redeker A, Reynolds T. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524-9
39. Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, Perla F, Deisidime M, Gusmaroli G, Bergamini L. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 1986;36:238-43
40. Dyck PJ, O’Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, Mokri B, Swift T, Low PA, Windebank AJ. Prednisone improves chronic inflammatory demyelinat- ing polyradiculoneuropathy more than no treatment. Ann Neurol 1982;11:136-41
41. Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970;211:1681-3
42. European Association for the Study of the Liver. Randomised trial of steroid therapy in acute liver failure. Gut 1979;20:620-3
43. Evans JA, Morrison IM, Saunders KB. A controlled trial of prednisone, in low dosage, in patients with chronic airways obstruction. Thorax 1974;29:401-6
44. Faupel G, Reuten HJ, Müller D, Schiirmann K. Double-blind study on the effects of steroids on severe closed head injury. In: Pappius HM, Feindei W, eds. Dynamics of brain edema. New York: Springer Verlag, 1976;337-43
45. Goodman DH. Comparative study of cloprednol versus placebo in asthma. Ann Allergy 1978;40:376-80
46. Gregory PB, Knauer CM, Kempson RL, Miller R. Steroid therapy in severe viral hepatitis. A double-blind, randomized trial of methyl-prednisolone versus placebo. N Engl J Med 1976;294:681-7
47. Harris ED Jr, Emkey RD, Nichols JE, Newberg A. Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983;10:713-21
48. Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avigan MI, Waggoner JG, Jones EA, Seeff LB. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1986;104:12-7
49. Howard FM Jr, Duane DD, Lambert EH, Daube JR. Alternate-day prednisone: preliminary report of a doubleblind controlled study. Ann NY Acad Sei 1976;274:596-607
50. Helman RA, Temko MH, Nye SW, Fallon HJ. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311-21
51. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978;2:750-3
52. James DG, Carstairs LS, Trowell J, Sharma OP. Treatment of sarcoidosis. Report of a controlled therapeutic trial. Lancet 1967;2:526-8
53. Koerner F, Merz A, Gloor B, Wagner E. Postoperative retinal fibrosis: a controlled clinical study of systemic steroid therapy. Graefes Arch Clin Exp Ophthalmol 1982;219: 268-71
54. Lam WK, So SY, Yu DYC. Response to oral corticosteroids in chronic airflow obstruction. Br J Dis Chest 1983;77:189-98
55. Lesesne HR, Bozymski EM, Fallon HJ. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978:74:169-73
56. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9
57. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jesdinsky H. European cooperatve Crohn’s disease study (ECCDS): results of drug treatment. Gastroenterology 1984;86:249-66
58. May M, Wette R, Hardin WB Jr, Sullivan J. The use of steroids in Bell’s palsy: a prospective controlled study. Laryngoscope 1976;86:1111-22
59. McQueen EG. Betamethasone in stroke [letter]. N Z MedJ 1978;87:103-4
60. Mendella LA, Manfreda J, Warren CPW, Anthonisen NR. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med 1982;96:17-21
61. Mitchell DM, Gildeh P, Rehahn M, Dimond AH, Collins JV. Effects of prednisolone in chronic airflow limitation. Lancet 1984;2:193-5
62. Morgan WKC, Rusche E. A controlled trial of the effect of steroids in obstructive airway disease. Ann Intern Med 1964;61:248-54
63. Mulley G, Wilcox RG, Mitchell JRA. Dexamethasone in acute stroke. Br Med J 1978;2:994-6
64. Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C. Effects of short-term, high-dose prednisone treatment of patients with HBsA-positive chronic active hepatitis. Liver 1985;5:8-12
65. Norris JW. Steroid therapy in acute cerebral infarction. Arch Neurol 1976;33:69-71
66. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. Br Med J 1986;292:21-3
67. O’Reilly JFO, Shaylor JM, Framings KM, Harrison BDW. The use of the 12 minute walking test in assessing the effect of oral steroid therapy in patients with chronic airways obstruction. Br J Dis Chest 1982;76:374-82
68. Patten BM, Mendell J, Braun B, Curtin W, Carter S. Double blind study of the effects of dexamethasone on acute stroke. Neurology 1972;22:377-83
69. Powell-TUck J, Bown RL, Chambers TJ, Lennard-Jones JE. A controlled trial of alternate day prednisolone as a maintenance treatment for ulcerative colitis in remission. Digestion 1981:22:263-70
70. Porter HP, Simon FR, Pope CEII, Volwiler W, Fenster LF. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. N Engl J Med 1971;284:1350-5
71. Prensky AL, Dodson WE. The steroid treatment of hereditary motor and sensory neuropathy. Neuropediatrics 1984; 15:203-7
72. Prout C, Dalrymple W. A double-blind study of eighty-two cases of infectious mononucleosis treated with corticosteroids. J Am Coll Health Assoc 1966;15:62-6
73. Rizza CR, Kernoff PBA, Matthews JM, McLennan CR, Rainsford SG. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease Thromb Haemost 1977;37:86-90
74. Schonfeld SA, Ploysongsang Y, Dilisio R, Crissman JD, Miller E, Hammerschmidt DE, Jacob HS. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med 1983;99:438-43
75. Shim C, Stover DE, Williams MH Jr. Response to corticosteroids in chronic bronchitis. J Allergy Clin Immunol 1978;62:363-7
76. Shumaker JB, Resnick RH, Galambos JT, Makopour H, Iber FL. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis, with a note on published results in en- cephalopathic patients. Am J Gastroenterol 1978;69:443-9
77. Singleton JW, Law DH, Kelley ML Jr, Mekhjian HS, Sturdevant RAL. National Cooperative Crohn’s Disease Study: adverse reactions to study drugs. Gastroenterology 1979; 77:870-82
78. Soloway RD, Summerskill WHJ, Baggenstoss AH, Geall MG, Gitnick GL, Elveback LR, Schoenfield LJ. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastronenterology 1972;63:820-33
79. Strain DS, Kinasewitz GT, Franco DP, George RB. Effect of steroid therapy on exercise performance in patients with irreversible chronic obstructive pulmonary disease. Chest 1985;88:718-21
80. Summers RW, Switz DM, Sessions JT Jr, Becktel JM, Best WR, Kern F Jr, Singleton JW. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology 1979;77:847-69
81. Taverner D. Cortisone treatment of Bell’s palsy. Lancet 1954;2:1052-4
82. Tellez H, Bauer RB. Dexamethasone as treatment in cere brovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 1973;4:541-6
83. Theodossi A, Eddleston ALWF, Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982;23:75-9
84. Vakil BJ, Iyer SN, Shah SC, Gadgil RK, Wagholikar UN. A controlled trial of prednisolone in the treatment of infective hepatitis. J Indian Med Assoc 1965;45:357-62
85. Ware AJ, Jones RE, Shorey JW, Combes B. A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol 1974;62:130-3
86. Ware AJ, Cuthbert JA, Shorey J, Gurian LE, Eigenbrodt EH, Combes B. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis. Gastroenterology 1981;80:219-4
87. Wolf SM, Wagner JH Jr, Davidson S, Forsythe A. Treatment of Bell’s palsy with prednisone: a prospective randomized study. Neurology 1978;28:158-61
88. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A doubleblind clinical study. Arch Otolaryngol 1980;106:772-6
89. Young RL, Harkleroad LE, Lordon RE, Weg JG. Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med 1970;73:207-12
90. Haynes RC Jr, Murad F. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs: inhibitors of adrenocortical steroid biosynthesis. In: Gilman AG, Goodman LS, Rail TW, Murad F, eds. The pharmacological basis of therapeutics. 7th ed. New York: MacMillan Publishing, 1985;1459-89
91. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-48
92. Katz D, Baptista J, Azen SP, Pike MC. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics 1978;34:469-74
93. Armitage P. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1971
94. Frey FJ. Kinetics and dynamics of prednisolone. Endocr Rev1987;8(4):453-73
95. Bergrem H. The influence of uremia on pharmacokinetics and protein binding of prednisolone. Acta Med Scand 1983;213:333-8
96. Frey FJ, Schaad H J, Renner EL, Horber FF, Frey BM, Preisig R. Liver function in stable renal transplant patients. Hepa- tology 1989;9(4):606-13
97. Frey BM, Frey FJ. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures. J Clin Endocrinol Metab 1985;60: 361-9
98. Renner E, Horber FF, Jost G, Frey BM, Frey FJ. Effect of liver function on the metabolism of prednisone and prednisolone in humans. Gastroenterology 1986;90:819-28
99. Zürcher RM, Frey BM, Frey FJ. Impact of ketoconazole on the metabolism of prednisolone. Clin Pharmacol Ther 1989;45:366-72
100. Stuck AE, Frey BM, Frey FJ. Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin Pharmacol Ther 1988;43:354-62
101. Frey FJ, Frey BM. Urinary 6-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism. J Lab Clin Med 1983;101:593-604
102. Frey BM, Frey FJ. Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans. Eur J Clin Invest 1984;14:1-6
103. Frey FJ, Horber FF, Frey BM. Altered metabolism and decreased efficacy of prednisolone and prednisone in hyperthyroid patients. Clin Pharmacol Ther 1989;44(5):510-21